METABOLISM-CLINICAL AND EXPERIMENTAL

Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence.

Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: think out of the box!

The incretin system in healthy humans: The role of GIP and GLP-1.

The pathogenesis of obesity.

Extracellular vesicles from human umbilical cord blood ameliorate bone loss in senile osteoporotic mice.

Systemic PPARγ deletion in mice provokes lipoatrophy, organomegaly, severe type 2 diabetes and metabolic inflexibility.

Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH).

Environment and obesity.

Traumatic brain injury (TBI) in collision sports: Possible mechanisms of transformation into chronic traumatic encephalopathy (CTE).

TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.

SIRT1 activation rescues the mislocalization of RNA-binding proteins and cognitive defects induced by inherited cobalamin disorders.

The glycoprotein follistatin-like 1 promotes brown adipose thermogenesis.

Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation.

Adropin Regulates Cardiac Energy Metabolism and Improves Cardiac Function and Efficiency.

Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice.

Novel aspects of the role of the liver in carbohydrate metabolism.

Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome.

Maternal, neonatal insulin resistance and neonatal anthropometrics in pregnancies following bariatric surgery.

Epigenetic impact of the social and physical environment on brain and body.

Physiology of energy homeostasis: Models, actors, challenges and the glucoadipostatic loop.

High-resolution metabolomics study revealing L-homocysteine Sulfinic acid, Cysteic acid, and Carnitine as novel biomarkers for high acute myocardial infarction risk.

Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB).

Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery?

The role of metabolism in the pathogenesis of systemic sclerosis.

LSD1 mediates microbial metabolite butyrate-induced thermogenesis in brown and white adipose tissue.

Central obesity transition increased urinary levels of 8-hydroxydeoxyguanosine in male adults: A 3-year follow up study.

Urban environment and psychiatric disorders: a review of the neuroscience and biology.

Peroxisomal gene and protein expression increase in response to a high-lipid challenge in human skeletal muscle

Association between obesity and biomarkers of inflammation and metabolism with cancer mortality in a prospective cohort study.

Characteristics of bile acids metabolism profile in the second and third trimesters of normal pregnancy.

LC3 promotes the nuclear translocation of the vitamin D receptor and decreases fibrogenic gene expression in proximal renal tubules.

Perinatal programming of metabolic diseases: the role of glucocorticoids.

Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes.

Angiotensin-(1-7) induces beige fat thermogenesis through the Mas receptor.

VO2max is associated with measures of energy expenditure in sedentary condition but does not predict weight change.

Fractional turnover of apolipoprotein(a) and apolipoprotein B-100 within plasma lipoprotein(a) particles in statin-treated patients with elevated and normal Lp(a) concentration.

PAQR3 modulates blood cholesterol level by facilitating interaction between LDLR and PCSK9.

The association between GAD65 antibody levels and incident Type 2 Diabetes Mellitus in an adult population: A meta-analysis.

Impaired antioxidative activity of high-density lipoprotein is associated with more severe acute ischemic stroke.

Central Sfrp5 regulates hepatic glucose flux and VLDL- triglyceride secretion.

The Adiponectin receptor agonist AdipoRon normalizes glucose metabolism and prevents obesity but not growth retardation induced by glucocorticoids in young mice.

Risk of coronary artery disease according to glucose abnormality status and prior coronary artery disease in Japanese men.

FoxO1 regulates leptin-induced mood behavior by targeting tyrosine hydroxylase.

Acute hypoxia reduces exogenous glucose oxidation, glucose turnover, and metabolic clearance rate during steady-state aerobic exercise.

Interaction between an SGLT2 inhibitor and exercise training.

Activation of G0/G1 Switch Gene 2 by Endoplasmic Reticulum Stress Enhances Hepatic Steatosis.

FGF21 in NAFLD.